3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Lymphoma
2
Sarcoma
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Mixed Dementias
1
Lymphoma, Follicular
1
Lung Neoplasms
1
Lewy Body Disease
1
Kidney Neoplasms
1
Dementia, Vascular
1
Dementia
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Breast Neoplasms
1
Interventions
pembrolizumab
6
Paclitaxel
4
Cyclophosphamide
4
Psychiatric Rehabilitation
3
Flow Cytometry
3
Filgrastim
3
Drug Therapy
3
Carboplatin
3
valspodar
2
trametinib
2
sargramostim
2
epacadostat
2
dabrafenib
2
X-Rays
2
Specimen Handling
2
Nivolumab
2
Microarray Analysis
2
Methylprednisolone
2
Melphalan
2
Injections
2
Immunologic Techniques
2
Gemcitabine
2
Dexamethasone
2
Dasatinib
2
Biopsy
2
Azacitidine
2
Analgesia
2
Amifostine
2
Alemtuzumab
2
vocimagene amiretrorepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Referral and Consultation
×
Lymphoid
×
Clear all
NCT02821793
2025-07-01
PRIORITY
Institut Bergonié
Completed
346 enrolled
9 charts